REFERENCES
- Watkins T, Surowiecka MK, McCullough J. Transfusion indications for
patients with cancer. Cancer Control. 2015;22:38-46.
- Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins
JS. Trends in transfusion burden among long-term survivors of
childhood hematological malignancies. Leuk lymphoma.
2013;54:1719-1723.
- Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B.
Hepatic iron concentration combined with long-term monitoring of serum
ferritin to predict complications of iron overload in thalassaemia
major. Br J Haematol. 2000;110:971-977.
- Wood JC. Magnetic resonance imaging measurement of iron overload. Curr
Opi Hematol. 2007;14:183-190.
- Kirk P, He T, Anderson LJ, et al. International reproducibility of
single breathhold T2* MR for cardiac and liver iron assessment among
five thalassemia centers. J Magn Reson Imaging. 2010;32:315-319.
- Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance
imaging of the liver in patients with iron overload. Blood.
2009;113:4853-4855.
- Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and
cardiac iron. Circulation. 2011;123:1519-1528.
- Vora A, Goulden N, Wade R, et al. Treatment reduction for children and
young adults with low-risk acute lymphoblastic leukaemia defined by
minimal residual disease (UKALL 2003): a randomised controlled trial.
Lancet Oncol. 2013;14:199-209.
- Burnett AK, Russell NH, Hills RK, et al. Optimization of chemotherapy
for younger patients with acute myeloid leukemia: results of the
medical research council AML15 trial. J Clin Oncol. 2013;31:3360-3368.
- Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y. Impact
of iron overload and potential benefit from iron chelation in low-risk
myelodysplastic syndrome. Blood. 2014;124:873-881.
- Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol
Appl Pharmacol. 2005;202:199-211.
- Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines
for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd
edition. Nicosia, Cyprus. 2014.
- Weinberg ED. The hazards of iron loading. Met Integr Biometal Sci.
2010;2:732-740.
- Hartmann J, Braulke F, Sinzig U, et al. Iron overload impairs
proliferation of erythroid progenitors cells (BFU-E) from patients
with myelodysplastic syndromes. Leuk Res. 2013;37(3):327–332.
- Weinberg ED. Iron withholding: a defense against viral infections.
Biometals Int J Role Met Ions Biol Biochem Med. 1996;9(4):393–399.
- Weinberg ED. Iron in neoplastic disease. Nutr Cancer. 1983;4:223–233
- Koreth J, Antin JH. Iron overload in hematologic malignancies and
outcome of allogeneic hematopoietic stem cell transplantation.
Haematologica. 2010;95:364-366.
- Barton JC, Bertoli LF. Transfusion iron overload in adults with acute
leukemia: manifestations and therapy. Am J Med Sci. 2000;319:73-78.
- Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, Mäkipernaa A.
Iron overload in children who are treated for acute lymphoblastic
leukemia estimated by liver siderosis and serum iron parameters.
Pediatrics. 2003;111:91-96.
- Olcay L, Hazirolan T, Yildirmak Y, et al. Biochemical, radiologic,
ultrastructural, and genetic evaluation of iron overload in acute
leukemia and iron-chelation therapy. J Pediatr Hematol Oncol.
2014;36:281-292.
- Nair M, Kuttath V, Nair AR, et al. Iron Overload in Children with
Leukemia Receiving Multiple Blood Transfusions. Indian Pediatr.
2018;55:962-965.
- Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR.
Characterization of transfusion-derived iron deposition in childhood
cancer survivors. Cancer Epidemiol Biomark. 2014;23:1913–1919.
- Schempp A, Lee J, Kearney S, Mulrooney DA, Smith AR. Iron Overload in
Survivors of Childhood Cancer. J Pediatr Hematol Oncol.
2016;38:27–31.
- Au WY, Lam WM, Chu WC, et al. A magnetic resonance imaging study of
iron overload in hemopoietic stem cell transplant recipients with
increased ferritin levels. Transplant Proc. 2007;39:3369-3374.
- Vag T, Kentouche K, Krumbein I, et al. Noninvasive measurement of
liver iron concentration at MRI in children with acute leukemia:
initial results. Pediatr Radiol. 2011;41:980-984.
- Unal S, Cetin M, Hazirolan T, et al. Number of erythrocyte
transfusions is more predictive than serum ferritin in estimation of
cardiac iron loading in pediatric patients with acute lymphoblastic
leukemia. Leuk Res. 2014;38:882-885.
- Chirico V, Rigoli L, Lacquaniti A, et al. Endocrinopathies, metabolic
disorders, and iron overload in major and intermedia thalassemia:
serum ferritin as diagnostic and predictive marker associated with
liver and cardiac T2* MRI assessment. Eur J Haematol.
2015;94:404-412.
- Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with
acute leukemia or MDS undergoing myeloablative stem cell
transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow
Transplant. 2011;17:852-860.
- de Ville de Goyet M, Moniotte S, Robert A, et al. Iron overload in
children undergoing cancer treatments. Pediatr Blood Cancer.
2013;60:1982-1987.
- Rascon J, Rageliene L, Stankeviciene S, et al. An assessment of iron
overload in children treated for cancer and nonmalignant hematologic
disorders. Eur J Pediatr. 2014;173:1137-1146.
- Gurram MK, Newman W, Kobrinsky N. Prevalence of iron overload in
pediatric oncology patients after blood transfusion. Clin Adv Hematol
Oncol HO. 2012;10:363-365.
- Acar S, Gözmen S, Bayraktaroğlu S, et al. Evaluation of Liver Iron
Content by Magnetic Resonance Imaging in Children with Acute
Lymphoblastic Leukemia after Cessation of Treatment. Turk J Haematol.
2020;37:263-270.
- Sait S, Zaghloul N, Patel A, et al. Transfusion related iron overload
in pediatric oncology patients treated at a tertiary care centre and
treatment with chelation therapy. Pediatr Blood Cancer.
2014;61:2319-2320.
- Sirvent A, Auquier P, Oudin C, et al. Prevalence and risk factors of
iron overload after hematopoietic stem cell transplantation for
childhood acute leukemia: a LEA study. Bone Marrow Transplant.
2017;52:80-87.
- Ktena YP, Athanasiadou A, Lambrou G, Adamaki M, Moschovi M. Iron
chelation with deferasirox for the treatment of secondary
hemosiderosis in pediatric oncology patients: a single-center
experience. J Pediatr Hematol Oncol. 2013;35:447-450.
- Armstrong GT, Plana JC, Zhang N, et al. Screening adult survivors of
childhood cancer for cardiomyopathy: comparison of echocardiography
and cardiac magnetic resonance imaging. J Clin Oncol Off J Am Soc Clin
Oncol. 2012;30:2876-2884.
- Ylänen K, Poutanen T, Savikurki-Heikkilä P, Rinta-Kiikka I, Eerola A,
Vettenranta K. Cardiac magnetic resonance imaging in the evaluation of
the late effects of anthracyclines among long-term survivors of
childhood cancer. J Am Coll Cardiol. 2013;61:1539-1547.
- Cheung Y-F, Lam WW-M, Ip JJ-K, et al. Myocardial iron load and
fibrosis in long term survivors of childhood leukemia. Pediatr Blood
Cancer. 2015;62:698-703.
- Lutz K, von Komorowski G, Dürken M, Engelhardt R, Dinter DJ.
Myocardial iron overload in transfusion-dependent pediatric patients
with acute leukemia. Pediatr Blood Cancer. 2008;51:691-693.